{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 is required for maintaining normal mitochondrial membrane potential (ΔΨ m) and mitochondrial morphology. Loss of PINK1 function causes depolarized ΔΨ m, fragmented mitochondria, and increased oxidative stress in dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism as PINK1-dependent maintenance of mitochondrial function and its role in preventing oxidative stress."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging, mitochondrial membrane potential assays, ROS measurement, and rescue experiments with wild-type PINK1 were used to assess mitochondrial function and oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The assays (mitochondrial morphology, ΔΨ m, ROS measurement) directly model the disease mechanism described in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "PINK1-null neurons served as the 'abnormal/positive/null' control, while wild-type neurons and overexpressed PINK1 rescued mitochondrial dysfunction. Mutant variants (G309D, E417G, CΔ145) failed to rescue, confirming functional defects.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type, knockout) and variant-specific functional assays were included. The rescue experiments with wild-type PINK1 and failure of mutants to rescue demonstrate valid assay application.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "PARK6 mutant (G309D) PINK1 failed to rescue mitochondrial dysfunction and inhibit oxidative stress in PINK1-deficient neurons.",
          "judgment": "Yes",
          "reasoning": "The variant (G309D) failed to rescue mitochondrial dysfunction, directly linking it to loss of PINK1 function. No statistical analysis (e.g., OddsPath) was explicitly reported.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested three mutant variants (G309D, E417G, CΔ145) and one wild-type control. No explicit count of benign/pathogenic controls was provided.",
          "judgment": "No",
          "reasoning": "The paper does not specify the total number of control variants used. However, the clear functional failure of these mutants to rescue mitochondrial dysfunction provides strong evidence.",
          "next_step_or_outcome": "Apply Max PS3_supporting"
        }
      ],
      "strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "E",
          "alt": "G",
          "position": "417"
        },
        "variant_string_id": "PINK1 E417G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 is required for maintaining normal mitochondrial membrane potential (ΔΨ m) and mitochondrial morphology. Loss of PINK1 function causes depolarized ΔΨ m, fragmented mitochondria, and increased oxidative stress in dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism as PINK1-dependent maintenance of mitochondrial function and its role in preventing oxidative stress."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging, mitochondrial membrane potential assays, ROS measurement, and rescue experiments with wild-type PINK1 were used to assess mitochondrial function and oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The assays (mitochondrial morphology, ΔΨ m, ROS measurement) directly model the disease mechanism described in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "PINK1-null neurons served as the 'abnormal/positive/null' control, while wild-type neurons and overexpressed PINK1 rescued mitochondrial dysfunction. Mutant variants (G309D, E417G, CΔ145) failed to rescue, confirming functional defects.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type, knockout) and variant-specific functional assays were included. The rescue experiments with wild-type PINK1 and failure of mutants to rescue demonstrate valid assay application.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "PARK6 mutant (E417G) PINK1 failed to rescue mitochondrial dysfunction and inhibit oxidative stress in PINK1-deficient neurons.",
          "judgment": "Yes",
          "reasoning": "The variant (E417G) failed to rescue mitochondrial dysfunction, directly linking it to loss of PINK1 function. No statistical analysis (e.g., OddsPath) was explicitly reported.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested three mutant variants (G309D, E417G, CΔ145) and one wild-type control. No explicit count of benign/pathogenic controls was provided.",
          "judgment": "No",
          "reasoning": "The paper does not specify the total number of control variants used. However, the clear functional failure of these mutants to rescue mitochondrial dysfunction provides strong evidence.",
          "next_step_or_outcome": "Apply Max PS3_supporting"
        }
      ],
      "strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "C",
          "alt": "Δ145",
          "position": "145"
        },
        "variant_string_id": "PINK1 CΔ145"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "PINK1 is required for maintaining normal mitochondrial membrane potential (ΔΨ m) and mitochondrial morphology. Loss of PINK1 function causes depolarized ΔΨ m, fragmented mitochondria, and increased oxidative stress in dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly defines the disease mechanism as PINK1-dependent maintenance of mitochondrial function and its role in preventing oxidative stress."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Confocal imaging, mitochondrial membrane potential assays, ROS measurement, and rescue experiments with wild-type PINK1 were used to assess mitochondrial function and oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The assays (mitochondrial morphology, ΔΨ m, ROS measurement) directly model the disease mechanism described in Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "PINK1-null neurons served as the 'abnormal/positive/null' control, while wild-type neurons and overexpressed PINK1 rescued mitochondrial dysfunction. Mutant variants (G309D, E417G, CΔ145) failed to rescue, confirming functional defects.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type, knockout) and variant-specific functional assays were included. The rescue experiments with wild-type PINK1 and failure of mutants to rescue demonstrate valid assay application.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "PARK6 mutant (CΔ145) PINK1 failed to rescue mitochondrial dysfunction and inhibit oxidative stress in PINK1-deficient neurons.",
          "judgment": "Yes",
          "reasoning": "The variant (CΔ145) failed to rescue mitochondrial dysfunction, directly linking it to loss of PINK1 function. No statistical analysis (e.g., OddsPath) was explicitly reported.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested three mutant variants (G309D, E417G, CΔ145) and one wild-type control. No explicit count of benign/pathogenic controls was provided.",
          "judgment": "No",
          "reasoning": "The paper does not specify the total number of control variants used. However, the clear functional failure of these mutants to rescue mitochondrial dysfunction provides strong evidence.",
          "next_step_or_outcome": "Apply Max PS3_supporting"
        }
      ],
      "strength": "PS3_supporting"
    }
  ]
}